Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORMD-0801 in Type 2 Diabetes Mellitus
NCT03467932Phase 2Completed
- Sponsor
- Oramed Pharmaceuticals Inc.
- Start
- May 2018
- Primary completion
- Oct 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ORMD-0801 in type 2 diabetes mellitus (T2DM), sponsored by Oramed Pharmaceuticals Inc.. Started May 2018; status: completed.
02
Drugs
ORMD-0801
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03467932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467932.